Evolus is a force to be reckoned with in the attractive injectables market, having grown to a impressive 13% US market share with their Jeuveau toxin in just five years.
In this episode, we'll dive into the market dynamics and uncover the secrets behind Evolus' remarkable success. We'll also explore the potential implications of their current strategy and where it could take them next.
Podden och tillhörande omslagsbild pÄ den hÀr sidan tillhör
Greg âThe Elevator Pitch. InnehĂ„llet i podden Ă€r skapat av Greg âThe Elevator Pitch och inte av,
eller tillsammans med, Poddtoppen.